Form D — Exin Therapeutics, Inc.
0002109179-26-000001 · filed Feb 10, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,162,300
- Reported amount sold
- $2,162,300
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Exin Therapeutics, Inc.
- CIK
- 2109179
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 2261 MARKET STREET STE 22614
SAN FRANCISCO, CA 94114 - Phone
- (650) 942-3715
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gabriel Ocana Santero · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Ivan Alex Priela Lazarte · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Marko Tvrdic · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗